Microbelcaps n n o
Created in 1995, Microbelcaps is a spin-off resulting from the research activity of the University of Liege. Its microencapsulation technology - a coating on a microscopic scale that protects the molecule during production, ensures its conservation or modifies its behaviour. Microbelcaps’ products include microencapsulated vitamins B1, B6, B12 (Drug Master File, DMF) & C, microencapsulated flavours, papain, and plant extracts.
I
Advanced microencapsulation technology for the food and the pharmaceutical industries
v T e c h n o l
Recently, Microbelcaps has been designated by an American study as one of the world leaders in microencapsulation. It must be said that the company is very active in the field of R&D as evidenced by its numerous scientific publications. This recognition is welcome to consolidate its presence in niche markets that are escaping the multinationals, which is ideal for a technological SME like Microbelcaps!
n
Different projects collaborated with worldwide universities and research institutions reinforce our recognization on microencapsulation technology and enrich our capacity to produce more various products. Our works extended to develop atomized formulations made up of nanoparticles with which to improve the redispersion of the inhaled powder (Marshall plan, BIOFINA, Development of inhaled synergistic combination of the treatment of resistant respiratory infection, 2010-12); to invent self-healing concrete by adding encapsulated healing agents (CAPDESIGN, Encapsulation of polymeric healing agents in self-healing concrete: capsule design, M-era.Net, 2014-17), to conserve antibody in microencapsulated state in a medical kit for daily usage (PICABO, Mecatech, 2016-18).
o
In the field of pharmaceutical applications, Microbelcaps has acquired recognised expertise in the field of vitamins coated for direct compression with 97% vitamins and 3% HPMC: they are available as granules or pellets from 70 to 800 micrometers and have received two major certifications: Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP).
i
The originality of Microbelcaps involves the development of extraction, filtration, concentration, granulation and the drying of temperature sensitive products by spraying, fluidized bed and lyophillisation. In collaboration with the Walloon Center of Industrial Biology, the company developed various microencapsulation technologies (Patents: EP 0 462003 B1; US 54 56 985 Microcapsules of oily liquid; Microencapsulation of Erythromycin
t
and Clarithromycin using a spray-drying technique, J. microencapsulation, 1999, vol 16, N°5, 565-571). With these technologies Microbelcaps is able to provide a variety of products in many fields of applications: food, pharmaceutical, biotechnology and chemicals. The company can personally help you stabilize your molecules through its wide range of coatings. These technologies offer is made possible by high-performance equipment: a reactor blender, a filter plate, a concentrator-evaporator, an atomizer, a freeze, a fluidized bed and an extruder granulator.
a
I
n 2000 Microbelcaps joined hands with the University of Liege to carry out a research project funded by the Walloon Region for the production of natural flavors by biotechnological means (Green note). From 2005, the company expanded and moved to larger premises in the Science Park of Liege. Its new plant was mainly restricted to the fluidized bed coating and the preparation of pharmaceutical molecules for direct compression (such as vitamin B1 & B6).
o g
© Microbelcaps
137
y
Microbelcaps S.A. Allée des noisetiers 2D - Scientifique Park of Liège - 4031 Angleur Tel.: +32 (0)4 371 34 02 - Fax: +32 (0)4 243 02 36 Email: info@microbelcaps.be https://www.europages.co.uk/MICROBELCAPS/00000003993165-001.html
